Long
UCB S.A.
No trades
No trades
Compare with UCB S.A.
8.20 EUR
1.56 B EUR
7.74 B EUR
117.06 M
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Profile
Sector
Industry
CEO
Jean-Christophe Tellier
Website
Headquarters
Brussels
Founded
1925
IPO date
Jan 2, 1987
ISIN
BE0003739530
FIGI
BBG000BMYVN7
Identifiers
ISIN BE0003739530
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Long
UCB.BR short term bullish potential to challenge ATHConclusion:
A substantial break above 100, preferably above 107 signals a short term bullish potential, challenging ATH and beyond.
A drop below 75 on the other hand renders long term bearish or at least choppy consolidation.
For short term play targeting 108 minimally, with tight stop just under 96
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
3.713% YTM
Maturity dateMar 30, 2028
Coupon1.00% (Fixed)
3.695% YTM
Maturity dateNov 21, 2029
Coupon5.20% (Fixed)
3.698% YTM
Maturity dateMar 20, 2030
Coupon4.25% (Fixed)
0.999% YTM
Maturity dateOct 1, 2027
Coupon1.00% (Fixed)
See all UNC bonds
Weight0.08%
Market value527.35 M
Weight0.11%
Market value350.56 M
Weight0.13%
Market value246.96 M
Weight0.16%
Market value119.10 M
Weight2.31%
Market value93.70 M
Weight0.23%
Market value86.23 M
Weight0.09%
Market value83.89 M
Weight0.11%
Market value73.92 M
Weight0.04%
Market value59.28 M
Weight0.04%
Market value59.28 M
Weight0.04%
Market value59.28 M
Explore more ETFs
Frequently asked questions
The current price of UNC is 238.10 EUR — it has decreased by −0.46% in the past 24 hours. Watch UCB S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange UCB S.A. stocks are traded under the ticker UNC.
UNC stock has risen by 1.62% compared to the previous week, the month change is a −4.19% fall, over the last year UCB S.A. has showed a 36.45% increase.
We've gathered analysts' opinions on UCB S.A. future price: according to them, UNC price has a max estimate of 340.00 EUR and a min estimate of 212.00 EUR. Watch UNC chart and read a more detailed UCB S.A. stock forecast: see what analysts think of UCB S.A. and suggest that you do with its stocks.
UNC stock is 1.60% volatile and has beta coefficient of 0.62. Track UCB S.A. stock price on the chart and check out the list of the most volatile stocks — is UCB S.A. there?
Today UCB S.A. has the market capitalization of 45.25 B, it has increased by 1.57% over the last week.
Yes, you can track UCB S.A. financials in yearly and quarterly reports right on TradingView.
UCB S.A. is going to release the next earnings report on Jul 30, 2026. Keep track of upcoming events with our Earnings Calendar.
UNC earnings for the last half-year are 6.46 EUR per share, whereas the estimation was 4.96 EUR, resulting in a 30.18% surprise. The estimated earnings for the next half-year are 5.08 EUR per share. See more details about UCB S.A. earnings.
UCB S.A. revenue for the last half-year amounts to 4.25 B EUR, despite the estimated figure of 4.21 B EUR. In the next half-year revenue is expected to reach 4.06 B EUR.
UNC net income for the last half-year is 1.08 B EUR, while the previous report showed 475.00 M EUR of net income which accounts for 0.00% change. Track more UCB S.A. financial stats to get the full picture.
Yes, UNC dividends are paid annually. The last dividend per share was 1.01 EUR. As of today, Dividend Yield (TTM)% is 0.43%. Tracking UCB S.A. dividends might help you take more informed decisions.
UCB S.A. dividend yield was 0.43% in 2025, and payout ratio reached 12.39%. The year before the numbers were 0.51% and 17.36% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 21, 2026, the company has 10.12 K employees. See our rating of the largest employees — is UCB S.A. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UCB S.A. EBITDA is 2.64 B EUR, and current EBITDA margin is 23.16%. See more stats in UCB S.A. financial statements.
Like other stocks, UNC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UCB S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UCB S.A. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UCB S.A. stock shows the buy signal. See more of UCB S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.